MB

Mark G. Bock

Merck: 76 patents #42 of 9,382Top 1%
NA Novartis Ag: 22 patents #49 of 5,128Top 1%
NL Nodthera Limited: 4 patents #2 of 12Top 20%
SS Salk Institute For Biological Studies: 3 patents #133 of 521Top 30%
MI Mitobridge: 3 patents #12 of 40Top 30%
EC Eisai R&D Management Co.: 2 patents #329 of 817Top 45%
SP Synaptic Pharmaceutical: 2 patents #39 of 69Top 60%
📍 Lexington, MA: #14 of 2,299 inventorsTop 1%
🗺 Massachusetts: #213 of 88,656 inventorsTop 1%
Overall (All Time): #12,601 of 4,157,543Top 1%
107
Patents All Time

Issued Patents All Time

Showing 101–107 of 107 patents

Patent #TitleCo-InventorsDate
4479941 Renin inhibitory peptides having PHE.sup.13 delection Daniel F. Veber, Joshua S. Boger 1984-10-30
4454132 Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension Edward J. Cragoe, Jr., Robert L. Smith 1984-06-12
4390703 Intermediates for the resolution of some interphenylene-9-thia-11-oxo-12-azaprostanoic acids Robert M. Di Pardo 1983-06-28
4389525 Process for the resolution of some interphenylene 9-thia-11-oxo-12-azaprostanoic acids Robert M. Di Pardo 1983-06-21
4362724 Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic Edward J. Cragoe, Jr., Robert L. Smith 1982-12-07
4309430 Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same Robert L. Smith 1982-01-05
4309540 Substituted pyrazinyl-1,2,4-oxadiazoles Edward J. Cragoe, Jr., Robert L. Smith 1982-01-05